title: [Lung carcinoma. An unusual case of survival].
abstract: Lung cancer incidence is continuously increasing over the world, despite significant advances in both the diagnostic and therapeutic fields. At the diagnosis, more than 2/3 of patients present a locally advanced disease associated with a 5-year survival of less than 35%, or with distant metastases associated with no long-time survival. Chemotherapy with cisplatin remains a well established option in the treatment of lung cancer, as confirmed by recent meta-analyses, and its action seems strengthened by the introduction of new agents (taxans, gemcitabine, vinorelbine, topotecan, and others), that are giving promising results for a better control of this disease.
authors.affiliation: Dipartimento di Scienze Cardio-Toraciche e Respiratorie, Cattedra di Chirurgia Toracica, II Università, Napoli. mdvs.t@tin.it
authors.forename: Michele
authors.initials: M
authors.lastname: Della Vittoria Scarpati
authors.forename: Giovanni
authors.initials: G
authors.lastname: Vicidomini
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Della Vittoria Scarpati
authors.forename: Mario
authors.initials: M
authors.lastname: Santini
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D017741:Survivors
vernacular_title: Carcinoma del polmone. Un caso non comune di sopravvivenza.